Arthur J. Gallagher & Co. (AJG)
NYSEFinancialsInsurance - BrokersSnapshot 2026-10-29
NYSEFinancialsInsurance - BrokersSnapshot 2026-10-29
Research Workspace
Put AJG beside peers and holdings, graph the same metric, and keep your notes with the evidence.
Daily closes. Earnings/event dots are placed inline.
Industries move in repeating boom-and-bust cycles. This shows where this stock’s industry sits in that cycle, stage by stage (recovery → expansion → supercycle → steady → deceleration → contraction), from its fundamentals (orders, revenue, capital spending), not the stock’s price.
A booming industry is a tailwind for the names in it; a contracting one is a headwind. Companies in the same industry tend to rise and fall together with the cycle, the way a tide lifts and lowers every boat in the harbor at once, so a large part of a stock’s swing can come from where its industry sits rather than from the company itself. It’s context for reading the company’s results, not a buy/sell call. Full explanation →
Financials is in steady. Describes the industry's cycle state, not a call on this stock.
The stage band shows the industry’s cycle over the chart’s timeline (each color a stage); a ▼ marks a quarter its growth inflected down — amber is an unconfirmed watch, red is confirmed the next quarter. Use “Overlay cycle on chart” to tint the price chart by stage. The industry’s fundamentals, not a signal on this stock.
Primary pillar under pressure — Maintain adjusted EBITDAC margin near 31%: Comparison needs review.
View ThesisRevenue growth is accelerating — up about 26% over the past year.
View GrowthRanks in the weakest quality tier of its industry — roughly the bottom 37%, softest on free-cash-flow yield.
View QualityMiddle-of-the-pack management execution.
View ManagementExpectations look high — the market is pricing in about 22% growth a year, above the roughly 12% analysts expect, leaving little room for error.
View ValuationModerate volatility — typically moves about 1% a day.
View RiskAJG’s growth case rests on organic expansion plus acquisitions, but revenue growth slowed from 28% to 24%. The latest quarter was inline, not a fresh beat. AJG trades at 21× P/E versus a 12× peer median, near its 22× history. The market is pricing in more growth than we forecast. A next-quarter miss probability of 20% and a lowered growth outlook challenge that premium. The margin pillar comparison needs review, so its pressure is unverified. Peer multiples imply a price about 22% below where it trades (it looks expensive on this basis); the thesis is on watch. This read is provisional.
Trailing returns as of 2026-10-29. AJG is total return (includes dividends); the S&P 500 benchmark is price return (the index excludes dividends).
Based on 23 analysts currently covering AJG (as of Oct 2026).
Based on 9 Wall Street analysts offering 12-month price targets for AJG in the last 4 months.
Continue this research
Compare AJG with peers and holdings, graph the same reported metric, keep your questions beside the evidence, and return when the facts change.
Compare now without an account. Saving and monitoring require an account.
| Compare | Company | Living FV | P/E | Revenue % | Quality |
|---|---|---|---|---|---|
| AJG Selected company | Graph | Compare | Trend | Review | |
| Peer Add a competitor | Graph | Compare | Trend | Review | |
| Holding Compare a holding | Graph | Compare | Trend | Review |
Selected metric trend
Quarterly · checked companies · value or % of revenue
A consensus fair price across 13 valuation methods, at three horizons. As of 2026-10-29. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A price-focused, side-by-side fair-value read versus Insurance Brokers — fair value, gap to price, and forward P/E.
Compare the value case
Put AJG next to peers and holdings, compare Living FV and multiples, then graph the driver behind the difference.
Threatens: Two-pronged revenue growth strategy: organic and M&A
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
End-of-day figures as of 2026-10-29. EPS is implied from price ÷ P/E. Not investment advice.
Current $268.20
The last 12 months of price, then the range of analyst 12-month targets from today’s $268.20.
Analyst ratings and price targets are third-party Wall Street estimates, not QuarterlyIQ’s view. Not investment advice.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Lowered growth outlook impacts revenue growth strategy.

Advances: Two-pronged revenue growth strategy: organic and M&A
Acquisition supports revenue growth strategy through M&A.

Advances: Two-pronged revenue growth strategy: organic and M&A
Surging revenue and earnings growth supports growth strategy.

Advances: Organic and M&A revenue growth strategy
Upgrade reflects positive organic growth outlook.